The Psychedelic Podcast cover image

Graham Pechenik - The Psychedelic Patent Puzzle: Unraveling the Impact on Innovation vs. Access

The Psychedelic Podcast

00:00

USONA vs. Compass Pathways

USONA has not filed any patents on psilocybin. Compass Pathways has patented a certain polymorph. Is there any sort of indication of who will get approved first from a clinical trial perspective? I can only imagine in the current climate trying to do drug discovery based purely on philanthropic funding is very difficult.

Play episode from 41:07
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app